Medical News

News > Health > Medical News > J&J withdraws fibroid treatment device from market

J&J withdraws fibroid treatment device from market

WASHINGTON (AP) — Johnson & Johnson is asking surgeons not to use a line of devices for removing growths from the uterus amid regulators' growing concern that the electronic surgical tools raise the risk of spreading cancer to other parts of the body. In April, J&J suspended sales of the devices, known as laparoscopic power morcellators, after the Food and Drug Administration discouraged doctors from using them. Surgeons use the devices to treat painful fibroids, either by removing the growths themselves or the entire uterus. J&J said Wednesday it is conducting a worldwide withdrawal of all its morcellators still on the market. The company cited an FDA meeting earlier this month that reinforced "the complexity of this issue." FDA is weighing regulatory actions to reduce the risk of cancer spread.

Medical News

EL PASO, Texas (AP) — More than 700 infants may have been exposed to tuberculosis at an El Paso hospital over the...
NEW YORK (AP) — Health officials say 22 states now have confirmed cases of an unusual respiratory illness in...
WASHINGTON (AP) — The top U.S. Army officer says thousands of promised American forces will be moving into Africa...
VALLETTA, Malta (AP) — Malta has refused entry to a cargo ship with a Filippino on board who was showing symptoms...
PARIS (AP) — Authorities say a French volunteer nurse infected with the Ebola virus is receiving experimental...